The SSAI fully supports the suspension of hydroxyethyl‐starch solutions commissioned by the European Medicines Agency
Authors:
- J. H. LaakeJLJ. H. Laake
- M. LipcseyMLM. Lipcsey
- E. WilkmanEWE. Wilkman
- V. PettiläVPV. Pettilä
- M. H. MøllerMMM. H. Møller
- the Board of the Scandinavian Society of Anaesthesiology Intensive Care Medicine (SSAI)T(the Board of the Scandinavian Society of Anaesthesiology Intensive Care Medicine (SSAI)
Open Access
- 16 April 2018
- journal article
- letter
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 62 (6) , 874-875
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hydroxyethyl starch solutions and patient harmThe Lancet, 2018
- Fluid therapy and outcome: a prospective observational study in 65 German intensive care units between 2010 and 2011Annals of Intensive Care, 2018
- Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney functionCochrane Database of Systematic Reviews, 2013
- Colloids versus crystalloids for fluid resuscitation in critically ill patientsCochrane Database of Systematic Reviews, 2013
- Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume ResuscitationJAMA, 2013
- Safety of Modern Starches Used During SurgeryAnesthesia & Analgesia, 2013
- Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive CareNew England Journal of Medicine, 2012
- Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe SepsisNew England Journal of Medicine, 2012
- Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trialsThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Preferences for colloid use in Scandinavian intensive care unitsActa Anaesthesiologica Scandinavica, 2008